Expert in Molecular Diagnostics, Drug Discovery, Medicinal Chemistry, Microbial Biofilm Biology
Expert ID: 737699 Pennsylvania, USA
Expert published one of the first papers on in silico modeling of two potential target proteins from the SARS-CoV-2 coronavirus; this research article has garnered over 190 citations since May 2020. He co-discovered the first quantum dot made from the red phosphorus allotrope fibrous phosphorous. He also authored the first paper contributing to the fundamental understanding of biofilm attachment to 3D printed materials.
During the COVID-19 pandemic, Expert was tasked with setting up and managing operations of the Employer COVID-19 molecular diagnostic laboratory. He worked to obtain the laboratory’s CLIA license and CAP accreditation. Currently, his role is Operations Director and oversees all day-to-day operations of the laboratory. He has also accepted an assistant professorship position in the Department of Microbiology and Immunology and Institute for Molecular Medicine and Infectious Disease at Employer starting July 2022.
|Year: 2020||Degree: Ph.D.||Subject: Chemical Biology / Medicinal Chemistry||Institution: Drexel University|
|Year: 2014||Degree: BS||Subject: Chemistry||Institution: York College of Pennsylvania|
|Years: 2020 to Present||Employer: Undisclosed||Title: Director of Operations||Department: DUCoM PDL/MDL CLIA/CAP Molecular Diagnostic Laboratory|
Responsibilities:Oversee all operations of DUCoM PDL/MDL CLIA/CAP certified Molecular Diagnostic Laboratory.